[{"Assets_0_Q2_USD":38666400000.0,"EarningsPerShareDiluted_2_Q2_USD":5.84,"EarningsPerShareDiluted_1_Q2_USD":1.44,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":950400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":920800000.0,"EarningsPerShareBasic_2_Q2_USD":5.86,"EarningsPerShareBasic_1_Q2_USD":1.44,"StockholdersEquityConverted_0_Q2_USD":2857300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":954200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":924600000.0,"StockholdersEquity_0_Q2_USD":2780500000.0,"RevenuesConverted_2_Q2_USD":10728900000.0,"RevenuesConverted_1_Q2_USD":5636700000.0,"NetIncomeLossConverted_2_Q2_USD":5568800000.0,"NetIncomeLossConverted_1_Q2_USD":1327200000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":1362800000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":1.29,"CommonStockDividendsPerShareDeclared_2_Q2_USD":1.29,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20190802"}]